Avid Bioservices, Inc.
CDMODelisted Feb 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000704562
Avid Bioservices, Inc. was delisted on Feb 5, 2025; its insiders filed their last Form 4 on Feb 7, 2025; 196 institutions reported holding it in 13F filings for Q4 2024, worth $840.8M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 196
- Q4 2024, +25 vs. previous quarter
- 13F value
- $840.8M
- Reported value at the end of Q4 2024
- Superinvestors holding
- 0
- At the end of Q4 2024
Superinvestors holding CDMO, Q4 2024
No superinvestor reported holding CDMO at the end of Q4 2024.
Latest insider trades
Open-market purchases and sales by Avid Bioservices, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Richieri Richard A.Chief Operations Officer | SSaleCommon Stock, $0.001 par value | −2.28K | $12.37 | −$28.2K | −4.4%49.5K after | |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Richieri Richard A.Chief Operations Officer | SSaleCommon Stock, $0.001 par value | −200 | $12.37 | −$2.47K | −2.2%8.79K after | |
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Richieri Richard A.Chief Operations Officer | SSaleCommon Stock, $0.001 par value | −3.84K | $12.22 | −$47.0K | −7.9%44.6K after | |
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Kwietniak Matthew R.Chief Commercial Officer | SSaleCommon Stock, $0.001 par value | −13.4K | $12.22 | −$163.6K | −20.9%50.8K after | 2 lots |
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Hart Daniel RChief Financial Officer | SSaleCommon Stock, $0.001 par value | −22.8K | $12.22 | −$278.8K | −17.1%111.0K after | 2 lots |
| Dec 27, 2024 (view filing) | Dec 26 | 1 day | Green Nicholas StewartPresident & CEO | SSaleCommon Stock, $0.001 par value | −145.9K | $12.22 | −$1.78M | −48.1%157.6K after | 2 lots |
| Dec 26, 2024 (view filing) | Dec 20-24 | 6 days | Green Nicholas StewartPresident & CEO | SSaleCommon Stock, $0.001 par value | −226.7K | $12.29 | −$2.79M | −100.0%0 after | 3 lots |
| Oct 15, 2024 (view filing) | Oct 14 | 1 day | Kwietniak Matthew R.Chief Commercial Officer | SSaleCommon Stock, $0.001 par value | −119 | $10.15 | −$1.21K | −0.5%25.4K after | |
| Oct 11, 2024 (view filing) | Oct 10 | 1 day | Richieri Richard A.Chief Operations Officer | SSaleCommon Stock, $0.001 par value | −2.03K | $10.05 | −$20.4K | −5.1%37.7K after | |
| Oct 11, 2024 (view filing) | Oct 10 | 1 day | Richieri Richard A.Chief Operations Officer | SSaleCommon Stock, $0.001 par value | −201 | $10.05 | −$2.02K | −2.7%7.22K after |
Top 10 13F holders, Q4 2024
The largest institutional positions in Avid Bioservices, Inc. at the end of Q4 2024; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,262,221 | $65.0M | 0.00% | +3,022+0.1% | Added |
| AltraVue Capital, LLC | 3,797,813 | $46.9M | 3.91% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,771,069 | $46.6M | 0.00% | −75,314−2.0% | Reduced |
| Glazer Capital, LLC | 3,717,200 | $45.9M | 3.11% | +3,717,200 | New |
| Punch & Associates Investment Management, Inc. | 2,884,154 | $35.6M | 1.94% | −49,379−1.7% | Reduced |
| State Street Corp | 2,673,621 | $33.0M | 0.00% | −328,882−11.0% | Reduced |
| FIL Ltd | 2,558,532 | $31.6M | 0.03% | +2,558,532 | New |
| Royal Bank of Canada | 2,506,731 | $31.0M | 0.01% | −321,097−11.4% | Reduced |
| Goldman Sachs Group Inc | 1,951,297 | $24.1M | 0.00% | +1,475,886+310.4% | Added |
| Alpine Associates Management Inc. | 1,946,082 | $24.0M | 1.46% | +1,946,082 | New |